Anti-MZB1/ MEDA-7/ PACAP functional antibody

Anti-MZB1/ MEDA-7/ PACAP functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to MZB1/MZB1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE1118-Ab-1/ GM-Tg-hg-SE1118-Ab-2Anti-Human MZB1 monoclonal antibodyHuman
GM-Tg-rg-SE1118-Ab-1/ GM-Tg-rg-SE1118-Ab-2Anti-Rat MZB1 monoclonal antibodyRat
GM-Tg-mg-SE1118-Ab-1/ GM-Tg-mg-SE1118-Ab-2Anti-Mouse MZB1 monoclonal antibodyMouse
GM-Tg-cynog-SE1118-Ab-1/ GM-Tg-cynog-SE1118-Ab-2Anti-Cynomolgus/ Rhesus macaque MZB1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE1118-Ab-1/ GM-Tg-felg-SE1118-Ab-2Anti-Feline MZB1 monoclonal antibodyFeline
GM-Tg-cang-SE1118-Ab-1/ GM-Tg-cang-SE1118-Ab-2Anti-Canine MZB1 monoclonal antibodyCanine
GM-Tg-bovg-SE1118-Ab-1/ GM-Tg-bovg-SE1118-Ab-2Anti-Bovine MZB1 monoclonal antibodyBovine
GM-Tg-equg-SE1118-Ab-1/ GM-Tg-equg-SE1118-Ab-2Anti-Equine MZB1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE1118-Ab-1/ GM-Tg-hg-SE1118-Ab-2; GM-Tg-rg-SE1118-Ab-1/ GM-Tg-rg-SE1118-Ab-2;
GM-Tg-mg-SE1118-Ab-1/ GM-Tg-mg-SE1118-Ab-2; GM-Tg-cynog-SE1118-Ab-1/ GM-Tg-cynog-SE1118-Ab-2;
GM-Tg-felg-SE1118-Ab-1/ GM-Tg-felg-SE1118-Ab-2; GM-Tg-cang-SE1118-Ab-1/ GM-Tg-cang-SE1118-Ab-2;
GM-Tg-bovg-SE1118-Ab-1/ GM-Tg-bovg-SE1118-Ab-2; GM-Tg-equg-SE1118-Ab-1/ GM-Tg-equg-SE1118-Ab-2
Products NameAnti-MZB1 monoclonal antibody
Formatmab
Target NameMZB1
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-MZB1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE1118-Ag-1Recombinant multi-species MZB1/ MEDA-7/ PACAP protein
    ORF Viral VectorvGMLP003843human MZB1 Lentivirus particle
    ORF Viral VectorpGMLP003843human MZB1 Lentivirus plasmid


    Target information

    Target IDGM-SE1118
    Target NameMZB1
    Gene ID51237,69816,291675,693572,100688475,101091341,510480,100072521
    Gene Symbol and Synonyms2010001M09Rik,MEDA-7,MZB1,PACAP,pERp1,RGD1310251
    Uniprot AccessionQ8WU39,Q561R0,A5PJ93
    Uniprot Entry NameMZB1_HUMAN,MZB1_RAT,MZB1_BOVIN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseCancer
    Gene EnsemblENSG00000170476
    Target ClassificationTumor-associated antigen (TAA)

    The target: MZB1, gene name: MZB1, also named as MEDA-7, PACAP, pERp1. Involved in positive regulation of cell population proliferation. Located in cytoplasm and extracellular region. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.